These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 29338117)
1. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma. Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117 [TBL] [Abstract][Full Text] [Related]
2. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD133 and other putative stem cell markers in uveal melanoma. Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792 [TBL] [Abstract][Full Text] [Related]
4. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity. Djirackor L; Kalirai H; Coupland SE; Petrovski G Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292 [TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance. van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640 [TBL] [Abstract][Full Text] [Related]
7. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis. Szalai E; Wells JR; Ward L; Grossniklaus HE Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399 [TBL] [Abstract][Full Text] [Related]
8. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of SPANX-C in metastatic uveal melanoma. Salvatorelli L; Puzzo L; Russo A; Reibaldi M; Longo A; Ragusa M; Aldo C; Rappazzo G; Caltabiano R; Salemi M Pathol Res Pract; 2019 Jul; 215(7):152431. PubMed ID: 31072624 [TBL] [Abstract][Full Text] [Related]
10. HSP-27 protein expression in uveal melanoma: correlation with predicted survival. Jmor F; Kalirai H; Taktak A; Damato B; Coupland SE Acta Ophthalmol; 2012 Sep; 90(6):534-9. PubMed ID: 21114636 [TBL] [Abstract][Full Text] [Related]
11. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425 [TBL] [Abstract][Full Text] [Related]
12. PRDX3 is associated with metastasis and poor survival in uveal melanoma. Ramasamy P; Larkin AM; Linge A; Tiernan D; McAree F; Horgan N; Moriarty P; Beatty S; Murphy CC; Clynes M; Kennedy S; Meleady P J Clin Pathol; 2020 Jul; 73(7):408-412. PubMed ID: 31771972 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients. Piperno-Neumann S; Servois V; Mariani P; Plancher C; Lévy-Gabriel C; Lumbroso-Le Rouic L; Couturier J; Asselain B; Desjardins L; Cassoux N J Fr Ophtalmol; 2015 Jun; 38(6):526-34. PubMed ID: 25978872 [TBL] [Abstract][Full Text] [Related]
14. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA; Bourne TD; Murali R Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622 [TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers. Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. van Beek JG; Koopmans AE; Vaarwater J; de Rooi JJ; Paridaens D; Naus NC; de Klein A; Verdijk RM; Kiliç E Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1284-91. PubMed ID: 24508790 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma. Greco IM; Calvisi G; Ventura L; Cerrito F Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562 [TBL] [Abstract][Full Text] [Related]
19. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases. Lin Z; Süsskind D J Cancer Res Clin Oncol; 2021 May; 147(5):1389-1405. PubMed ID: 33665679 [TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]